TY  - JOUR

T1  - Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer.

JO  - Br J Cancer

UR  - http://eprints.whiterose.ac.uk/80403/

PY  - 2006/11/06

AU  - Eggington S

AU  - Tappenden P

AU  - Pandor A

AU  - Paisley S

AU  - Saunders M

AU  - Seymour M

AU  - Sutcliffe P

AU  - Chilcott J

ED  - 

DO  - DOI: 10.1038/sj.bjc.6603348

VL  - 95

IS  - 9

SP  - 1195

EP  - 1201

Y2  - 2024/12/22

ER  -